UnitedHealth Group Inc.
Provides health insurance plans, pharmacy services, care management software, and health information systems to employers, government programmes, hospitals, and individual consumers across the United States and internationally.
As of Aug 31, 2026
Summary
UnitedHealth Group is a diversified healthcare company operating across insurance, medical services, and technology solutions. The stock carries a bullish technical bias despite a near-term pullback of 0.5% today and a one-month decline of 6.8%. Over the past year, UNH has returned 32.8%, trading at $392.95 with a market capitalisation of $353 billion.
Price history
As of Aug 28, 2026
Performance
-0.90%
+0.73%
-6.77%
+3.91%
+20.65%
+32.77%
As of Aug 28, 2026
Technical indicators
- 42.4
- 0.05Bullish
- 50: 412.83 · 200: 347.27
- $383.83 / $401.85
Technical Bias
Bullish lean
UnitedHealth Group Inc. trades at $392.95 with a mix of technical signals: MACD shows bullish momentum, while RSI at 42.4 and moving averages sit neutral. This derived technical read suggests a mildly bullish tilt overall, though the picture remains mixed rather than strongly directional.
A transparent read of the indicators below — not a prediction or recommendation.
As of Aug 28, 2026
Fundamentals
- $353B
- 25.38
- $15.48
- 3.14%
- +0.4%
- $16.1B
- 0.63
- $254.52 – $461.62
- 2.35%
- Sep 14, 2026
- Oct 27, 2026 (56 days)
As of Aug 31, 2026
Upcoming catalysts
- Ex-dividend date
- Earnings report
As of Aug 31, 2026
Latest news
As of Aug 31, 2026
MonkeyTrade's Take on UnitedHealth Group Inc.
Short-term outlook
The short-term setup on UnitedHealth leans cautiously constructive but far from decisive: MACD has flipped bullish even as RSI sits neutral at 42.4 and the stock is still nursing a 6.8% monthly loss. A push through $401.85 resistance would confirm the turn, while a slip under $383.83 support would undo it. With earnings not due until October 2026, there's no near-term catalyst to force the issue either way.
Medium-term outlook
UnitedHealth's numbers tell a mixed story medium-term: revenue growth has all but stalled at 0.4%, and a 3.1% profit margin is thin for a company of its scale, though the 2.4% dividend yield still offers some support alongside a reasonable 25.38 P/E. Yet the technical lean is bullish, suggesting the market is looking past current softness toward recovery. A meaningful pickup in revenue growth would be the key signal to confirm that optimism is warranted.
Key risks
- Profit margin sits at just 3.1%, a thin cushion that leaves little room for cost pressures or claims volatility to erode earnings.
- Revenue growth of only 0.4% year on year suggests the business is barely expanding, which is worth watching for a company of this scale.
- The current price of $392.95 remains well below the 52-week high of $461.62, showing the stock has not recovered the ground lost since that peak.
- As a major health insurer, UnitedHealth remains tied to sector-wide dynamics highlighted in recent peer coverage, including how rivals like Elevance Health are performing amid the same cost and regulatory backdrop.
About UnitedHealth Group Inc.
UnitedHealth Group is a major US healthcare company, listed on the NYSE under the ticker UNH. Sitting within the healthcare sector and specifically the healthcare plans industry, it stands as one of the largest players in this space, with a market capitalisation of $353B underlining its significant scale and influence in how healthcare coverage is delivered across the country.
Looking at its key figures helps put the company in context. A price-to-earnings ratio of 25.38 shows how the market currently values its earnings, giving investors a sense of the premium placed on its profits. Meanwhile, a dividend yield of +2.4% reflects the portion of returns paid out to shareholders, offering a glimpse into how the company balances rewarding investors with reinvesting in its operations.
How to trade UnitedHealth Group Inc.
Shares like this are usually traded as CFDs. Compare regulated brokers that offer share CFDs — weigh spreads, fees and platforms before you open an account.
AI-assisted research for informational purposes only — not investment advice. Figures are sourced from third-party market data and may be delayed. Do your own research before trading. Your capital is at risk. How we build these pages.